Explore

Trendline Trendline
Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares

Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares

Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares
Trendline Trendline
Innovent Biologics and Pfizer Sign $10.5 Billion Oncology Deal Impacting Global Markets

Innovent Biologics and Pfizer Sign $10.5 Billion Oncology Deal Impacting Global Markets

Innovent Biologics and Pfizer Sign $10.5 Billion Oncology Deal Impacting Global Markets
Trendline Trendline
Pfizer and Innovent Biologics Collaborate to Advance Oncology Medicines Globally

Pfizer and Innovent Biologics Collaborate to Advance Oncology Medicines Globally

Pfizer and Innovent Biologics Collaborate to Advance Oncology Medicines Globally
Trendline Trendline
Pfizer and Innovent Biologics Announce $10.5 Billion Cancer Treatment Collaboration

Pfizer and Innovent Biologics Announce $10.5 Billion Cancer Treatment Collaboration

Pfizer and Innovent Biologics Announce $10.5 Billion Cancer Treatment Collaboration
Trendline Trendline
Pfizer and Innovent Biologics Partner in $10.5 Billion Cancer Therapy Deal

Pfizer and Innovent Biologics Partner in $10.5 Billion Cancer Therapy Deal

Pfizer and Innovent Biologics Partner in $10.5 Billion Cancer Therapy Deal
Trendline Trendline
Pfizer and Innovent Biologics Forge $10.5 Billion Cancer Research Alliance

Pfizer and Innovent Biologics Forge $10.5 Billion Cancer Research Alliance

Pfizer and Innovent Biologics Forge $10.5 Billion Cancer Research Alliance
Trendline Trendline
PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member

PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member

PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member
Trendline Trendline
Verastem Oncology to Present at Jefferies Healthcare Conference 2026

Verastem Oncology to Present at Jefferies Healthcare Conference 2026

Verastem Oncology to Present at Jefferies Healthcare Conference 2026
Trendline Trendline
Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns
Trendline Trendline
Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity
Trendline Trendline
Olympus Acquires Israeli Medtech Firm BioProtect in $270 Million Deal

Olympus Acquires Israeli Medtech Firm BioProtect in $270 Million Deal

Olympus Acquires Israeli Medtech Firm BioProtect in $270 Million Deal
Trendline Trendline
Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors

Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors

Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors